Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Equity Ratio (2016 - 2026)

Collegium Pharmaceutical has reported Equity Ratio over the past 11 years, most recently at 0.18 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 32.36% year-over-year to 0.18; the TTM value through Dec 2025 reached 0.18, up 32.36%, while the annual FY2025 figure was 0.18, 32.36% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.18 at Collegium Pharmaceutical, up from 0.17 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.35 in Q2 2021 and troughed at 0.14 in Q4 2024.
  • A 5-year average of 0.19 and a median of 0.17 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: skyrocketed 47.24% in 2021 and later plummeted 55.25% in 2022.
  • Year by year, Equity Ratio stood at 0.29 in 2021, then plummeted by 43.4% to 0.17 in 2022, then rose by 3.01% to 0.17 in 2023, then dropped by 19.53% to 0.14 in 2024, then surged by 32.36% to 0.18 in 2025.
  • Business Quant data shows Equity Ratio for COLL at 0.18 in Q4 2025, 0.17 in Q3 2025, and 0.15 in Q2 2025.